Physician
Quinn Healthcare,pllc
Quinn Healthcare,pllc was paid $527K by Medicaid between Jan 2018 and Dec 2024, across 49 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 56% of everything it billed.
33Billing provider infoQUINN HEALTHCARE,PLLC
RIDGELAND, MS 39157
RIDGELAND, MS 39157
33aNPI1821103920assigned 08/20/2006
33bProvider typeDermatology Physician
28Total paid$527K
24GClaims30,930
24DCodes billed49
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Dermatology Physician providers in Mississippi
Rank by total paid#2 of 22
Median peer was paid$36K
This provider vs. median15×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,002 | $87K | |
| 2019 | 7,019 | $93K | |
| 2020 | 4,497 | $73K | |
| 2021 | 4,507 | $93K | |
| 2022 | 4,845 | $93K | |
| 2023 | 2,092 | $51K | |
| 2024incomplete | 1,968 | $38K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 56% | 8,285 | 6,795 | $297K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 7.6% | 671 | 590 | $40K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6.3% | 980 | 838 | $33K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3.9% | 2,357 | 1,913 | $21K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.3% | 247 | 189 | $17K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 3.0% | 491 | 463 | $16K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.8% | 1,711 | 1,392 | $15K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.6% | 1,593 | 1,244 | $14K |
| 92551 | 2.1% | 1,469 | 1,156 | $11K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.8% | 2,528 | 2,276 | $9K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1.3% | 213 | 157 | $7K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.2% | 583 | 472 | $7K |
37 more codes
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 1.0% | 51 | $5K |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 203 | $4K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 52 | $4K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 49 | $4K |
| 99173 | <1% | 1,476 | $3K | |
| 99401 | <1% | 309 | $3K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 30 | $3K |
| 93000 | <1% | 405 | $3K | |
| 80061 | Lipid panel | <1% | 300 | $2K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 95 | $2K |
| 96160 | <1% | 747 | $1K | |
| 85018 | <1% | 1,164 | $1K | |
| 99384 | <1% | 15 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,148 | $1K |
| 96127 | <1% | 438 | $961.70 | |
| 99442 | <1% | 33 | $887.74 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 29 | $785.28 |
| 99490 | Ccm add 20min | <1% | 99 | $712.44 |
| 82947 | <1% | 309 | $641.65 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 566 | $302.39 |
| 90686 | <1% | 101 | $224.65 | |
| 99491 | Ccm add 20min | <1% | 27 | $192.49 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 257 | $86.83 |
| 90756 | <1% | 17 | $66.84 | |
| 1159F | <1% | 150 | $6.48 | |
| 36416 | <1% | 567 | $5.75 | |
| 3288F | <1% | 108 | $4.69 | |
| 3725F | <1% | 223 | $2.92 | |
| 90649 | <1% | 101 | $0.16 | |
| 99497 | 0% | 182 | $0.00 | |
| 1090F | 0% | 58 | $0.00 | |
| 1160F | 0% | 59 | $0.00 | |
| 90715 | 0% | 12 | $0.00 | |
| 1170F | 0% | 256 | $0.00 | |
| 99606 | 0% | 88 | $0.00 | |
| 90733 | 0% | 18 | $0.00 | |
| 1126F | 0% | 60 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialQUINN, TIMOTHY (OWNER/PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Mercy Medical Center | Cedar Rapids, IA | $80K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.